cystamine has been researched along with fluorodeoxyglucose f18 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brownell, AL; Cicchetti, F; Jokivarsi, K; Saint-Pierre, M; Sarkar, A; Wang, X; Yu, M; Zhu, A | 1 |
1 other study(ies) available for cystamine and fluorodeoxyglucose f18
Article | Year |
---|---|
Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease.
Topics: Age Factors; Animals; Binding, Competitive; Body Weight; Brain; Brain Chemistry; Brain Mapping; Cerebral Cortex; Cystamine; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Fluorodeoxyglucose F18; Glucose; Huntington Disease; Image Processing, Computer-Assisted; Inclusion Bodies; Male; Mice; Mice, Transgenic; Motor Activity; Neuroprotective Agents; Peptides; Positron-Emission Tomography; Raclopride; Transglutaminases; Tritium | 2005 |